Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-004205

Interim CEO & General Counsel gave up 9,955 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 20,835 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Vogt Frederick G Interim CEO & General Counsel 2025-01-14 Option exercise +20,835 231,071 D
Vogt Frederick G Interim CEO & General Counsel 2025-01-14 Shares withheld for taxes −9,955 $5.89 $58,635 221,116 D
Derivatives
Vogt Frederick G Interim CEO & General Counsel 2025-01-14 Option exercise · Restricted Stock Units −20,835 0 D
Loading xslF345X05/tm253469-3_4seq1.xml…